2026年首个交易日，A股主要股指高开高走，沪指涨超1%重返4000点上方，创业板指涨近3%，科创50 指数大涨超4%。 盘面上看，保险、半导体、医药、有色等板块走强，券商、地产、石油、酿酒等板块上扬，人脑工程概 念爆发，存储芯片、创新药、AI应用概念等活跃。 中信证券认为，2026年最大的预期差来自于外需与内需的平衡，对外"征税"、补贴内需应是大势所趋， 今年是个重要的开端。站在开年，考虑到去年末的资金热度并不算高，人心思涨的环境下开年后市场震 荡向上的概率更高。前期共识性品种"调整后再上车"大概率是机构资金主要的考虑方向，例如有色、海 外算力、半导体自主可控等，当然有些偏游资风格的品种也属于这一类别，比如商业航天、机器人等。 反共识品种是一些配置型增量资金的考虑，典型的方向就是通过内需消费的小仓位增配去捕捉年内的超 预期政策变化，免税、航空等出行服务相关的行业应该是增量布局重点，优质的地产开发商也是考虑对 象。 （文章来源：证券时报网） 截至收盘，沪指涨1.38%报4023.42点，深证成指涨2.24%，创业板指涨2.85%，科创50指数涨4.4%，沪 深北三市合计成交25674亿元。 ...

Group 1 - The brain-computer interface sector experienced a strong surge on the first trading day of A-shares in 2026, with stocks like Botao Bio, Sino Medical, and Xiangyu Medical hitting the daily limit of 20% increase, leading to a 5.6% rise in the medical device ETF [1] - Elon Musk announced on social media that his brain-computer interface company Neuralink will begin "mass production" of brain-computer interface devices in 2026 [1] - In 2025, China approved 76 innovative drugs for market launch, significantly surpassing the 48 approved in 2024, marking a historical high [1] Group 2 - The medical device ETF (562600) rose by 5.65%, tracking the CSI All-Share Medical Device Index, with a high industry representation of 89% and a brain-computer interface content of 23.14%, outperforming other medical ETFs [1] - The Hang Seng Medical ETF (159892) increased by 6.07%, with a latest scale of 5.564 billion yuan, featuring top-weighted stocks such as BeiGene, WuXi Biologics, and CanSino Biologics [2] - The Hong Kong Stock Connect Medical ETF (520510) rose by 5.72%, leading the market in CXO concentration, with key stocks including WuXi Biologics, MicroPort, and JD Health [2]

Group 1: Global Stock Market Performance - The global stock indices in 2025 exhibited a clear "divergent upward" trend, with the South Korean Composite Index leading at 75.6% growth, significantly higher than other markets[4] - The second tier of performance was concentrated in Hong Kong and Northeast Asian markets, including the Hang Seng Index and Nikkei 225, with growth rates ranging from 23.0% to 31.1%[4] - European markets showed moderate performance, while global benchmarks and U.S. tech-related indices remained relatively strong[4] Group 2: Hong Kong Stock Market Insights - The Hong Kong Hang Seng Industry Index displayed a "strong structure, weak diffusion" characteristic, with materials leading at 161.3% growth, while defensive sectors like utilities and telecommunications lagged[6] - In 2025, the Hong Kong IPO market welcomed 117 new listings, raising approximately HKD 285.7 billion, with notable first-day performance from Nobikang (2635.HK) at 363.75%[9] - The largest fundraising project was CATL (3750.HK), which raised around HKD 41 billion, while 685 companies announced additional share placements, expected to raise about HKD 361.8 billion, mainly in TMT and financial sectors[9] Group 3: U.S. Economic Overview - In Q3 2025, the U.S. GDP growth rate was 4.3%, exceeding expectations of 3.3%, driven by resilient private consumption and improved net exports[10] - Personal consumption expenditures contributed 2.4 percentage points to GDP growth, indicating strong consumer resilience despite tariff impacts[10] - Market expectations for interest rate cuts have shifted to April and July 2026, with anticipated reductions of 25 basis points each[10] Group 4: Chinese Economic Trends - Industrial profits in China showed a slight year-on-year increase of 0.1% from January to November 2025, with notable growth in high-tech manufacturing sectors[11] - The solar and semiconductor industries are experiencing a new wave of growth, supported by policy adjustments and rising prices in key materials[11] - The government initiated a venture capital fund of HKD 100 billion to stimulate investment in high-tech sectors, including AI and quantum technology[11]

Core Viewpoint - The A-share market experienced a strong start in 2026, with the Shanghai Composite Index surpassing 4000 points and a notable increase in various sectors, particularly insurance, pharmaceuticals, and technology [2][6]. Group 1: Insurance Sector - The insurance sector saw significant gains, with major companies like New China Life and China Pacific Insurance reaching historical highs [4]. - Since Q3 2025, the insurance sector has been a stabilizing force in the market, benefiting from favorable policies such as the guidance on health insurance development and adjustments to risk factors for insurance companies [6]. - Looking ahead to 2026, the insurance sector is expected to maintain a competitive edge due to attractive returns on dividend insurance products and improvements in distribution channels, which may lead to positive growth in new business value (NBV) [7]. Group 2: Pharmaceutical Sector - The pharmaceutical sector experienced a broad rally, with significant increases in stocks of leading companies such as BeiGene and WuXi AppTec [9]. - In 2025, the number of approved innovative drugs reached 76, a 58.3% increase from 48 in 2024, marking a historical high [11]. - The outlook for 2026 is optimistic, with expectations that the innovative drug sector will dominate the pharmaceutical industry, supported by the integration of medical insurance and commercial insurance, which will enhance payment capabilities [13][14].

盘面上看，保险、半导体、医药板块涨幅居前，有色、家电、券商、地产等板块均上扬，人脑工程概念 爆发，创新药、存储芯片、光刻机概念等活跃。 5日早盘，两市股指盘中强势拉升，沪指涨超1%重返4000点上方，科创50指数大涨超4%，全A超4000股 飘红。 截至午间收盘，沪指涨1.07%报4011.45点，深证成指涨1.87%，创业板指涨2.15%，科创50指数涨 4.05%，沪深北三市合计成交16491亿元。 华西证券表示，春季躁动提前，牛市格局依旧未改。2026年是多个正面因素叠加的"大年"，牛市基础仍 扎实，且春季躁动已提前演绎：一是宏观政策周期来看，2026年作为"十五五"开局之年，多部门正密集 出台配套产业政策和投资规划，同时财政货币政策的协同发力，为市场营造了友好的流动性环境；二是 资金层面，12月以股票型ETF为代表的机构资金出现抢跑，后续保险资金"开门红"叠加汇率升值驱动下 外资回流，增量资金入市有望强化春季行情趋势；三是基本面预期与产业周期来看，随着PPI降幅收 窄，预计2026年企业盈利进入温和复苏通道，对盈利拐点的博弈将成为行情的重要支撑。 （文章来源：证券时报网） ...

2026年A股首个交易日，市场一片热闹景象。 一方面，上证指数再度站上4000点，日线迎来罕见的12连阳。另一方面，权重股搭台，个股普涨，热点全面开花。 权重股方面，保险板块大涨；此外，贵州茅台、宁德时代、中芯国际等龙头股均上涨。板块方面，脑机接口、医药、半导体、消费电子等板块大涨。 截至上午收盘，上证指数上涨1.07%，报4011.45点；深证成指上涨1.87%，创业板指上涨2.15%。 保险板块大涨 今天上午，保险板块大涨，五大险企集体上涨，新华保险、中国太保盘中股价均创历史新高。 从资产端来看，光大证券表示，随着投资资产规模持续稳健增长以及股票仓位维持在较高水平，权益市场上行将进一步提振险企投资收益表现，同时高股 息策略亦能有效支撑险企净投资收益安全垫，共同推动盈利释放。后续，随着经济预期逐步修复以及资本市场稳中向好，保险股贝塔行情有望持续演绎。 医药股上涨 今天上午，医药股全线走强，医疗服务、医疗器械、CRO等板块大涨，百济神州、药明康德、恒瑞医药等龙头股大涨。 博拓生物 | 小十十八四 | 14.95 | 1.55% | 156316 | | --- | --- | --- | --- | | ■ ...

2026年A股首个交易日，市场一片热闹景象。 一方面，上证指数再度站上4000点，日线迎来罕见的12连阳。另一方面，权重股搭台，个股普涨，热点全面开花。 权重股方面，保险板块大涨；此外，贵州茅台（600519）、宁德时代（300750）、中芯国际等龙头股均上涨。板块方面，脑机接口、医药、半导体、消费 电子等板块大涨。 截至上午收盘，上证指数上涨1.07%，报4011.45点；深证成指上涨1.87%，创业板指上涨2.15%。 | 新华保险 融 601336 | 74.95 | 7.53% | 1563 Z | | --- | --- | --- | --- | | 中国太保 | 44.49 | 6.16% | 3045亿 | | 融 601601 | | | | | 行业龙头3 | | | | | 中国平安 ■ 601318 | 72.20 | 5.56% | 7697亿 | | 行业龙头2 | | | | | 中国人寿 融 601628 | 47.85 | 5.16% | 9964 Z | | 行业龙头1 | | | | | 中国人保 融 601319 | 9.38 | 4.80% | 3330亿 | 202 ...

2．保险 新华保险涨超7%，中国太保涨超6%，续创历史新高。 1月5日消息，市场早盘高开高走，时隔34个交易日，上证指数盘中重回4000点。板块方面，脑机接口概 念盘中持续扩大涨幅，乐普医疗、海格通信、三七互娱（维权）等超20股涨停；半导体产业链持续走 强，东微半导、兆易创新等多股涨停；创新药概念表现活跃，百济神州涨超10%；保险板块强势领涨， 新华保险涨超7%，中国太保涨超6%，双双创历史新高；下跌方面，海南自贸概念集体大跌，海南发展 跌停；银行板块大面积飘绿，浦发银行领跌。总体来看，个股呈普涨态势，上涨个股超4000只。 截至收盘，沪指报4011.45点，涨1.07%；深证成指报13777.32点，涨1.87%；创指报3272.07点，涨 2.15%。 盘面上，脑机接口、高压氧舱、保险板块涨幅居前，海南自贸区、海南、机场航运板块跌幅居前。 热点板块： 1．脑机接口 乐普医疗、海格通信、三七互娱等超20股涨停。 消息面上，马斯克近日在社交媒体上表示，其脑机接口公司Neuralink将于2026年开始对脑机接口设备进 行"大规模生产"。 4、【高盛预计中国央行今年一季度有一次"双降"】据高盛最新宏观展望报告， ...

Group 1 - The Shanghai Stock Exchange Sci-Tech Innovation Board 100 Index (000698) rose by 2.30% as of January 5, 2026, with notable increases in constituent stocks such as BeiGene (688235) up 10.56%, Chengdu Huami (688709) up 10.46%, and Huashu High-Tech (688433) up 7.57% [1] - The semiconductor industry chain experienced a strong upward trend, driven by announcements from companies like Huahong Semiconductor regarding the acquisition of a 97.5% stake in Huali Microelectronics and Zhongwei's plan to acquire a 64.69% stake in Hangzhou Zhonggui Electronics [1] - Aijian Securities highlighted that the domestic semiconductor industry chain is making significant progress in core equipment, materials, and software, supported by national policies and international dynamics, particularly in the third-generation semiconductor materials, computing power chips, RF communication chips, and high-bandwidth storage sectors [1] Group 2 - The Sci-Tech Innovation 100 ETF (588800) closely tracks the Sci-Tech 100 Index, which is the first and only mid-cap style index on the Sci-Tech Innovation Board, focusing on high-growth technology companies, particularly in the semiconductor, pharmaceutical, and new energy sectors [2]

脑机接口概念股集体暴涨。 公历2026年首个交易日（1月5日）上午，A股市场强劲上行，其中上证指数向上突破4000点整数大关。 在上周五（1月2日）大涨后，上午港股市场涨势趋缓。 值得注意的是，受到相关消息提振，上午A股市场和港股市场的脑机接口概念股集体暴涨，相关个股掀涨停潮。 沪指冲上4000点 传媒、有色金属、计算机等板块涨幅亦居于市场前列。 石油石化板块走低，中国石油跌超4%，中国海油跌近4%，拖累该板块表现。 银行板块也整体走低，截至发稿，浦发银行跌近5%，中信银行、工商银行、中国银行、建设银行、农业银行等跌幅居前。 脑机接口概念爆发 概念板块方面，A股市场脑机接口概念大涨，相关概念股批量涨停。相关概念股中，倍益康30%涨停，博拓生物、三博脑科、狄耐克、冠昊生物、爱朋医 疗、翔宇医疗、伟思医疗、熵基科技、谱尼测试、麦澜德、乐普医疗等多股20%涨停，荣泰健康、创新医疗、南京熊猫等多股10%涨停，还有多股涨幅超 过10%。 | 脑科学(脑机接口)(02251393) Q C | | | | --- | --- | --- | | 午间休市 01-05 11:30:25 | | | | 1166.53 L1 ...